With many patients utilizing medical cannabis, it is important for nurses to be aware of potential drug-drug interactions, an expert said.

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

A nurse practitioner discusses how breast cancer treatment can impact sexual health, and how nurses and APPs can guide ...

October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

An ad-hoc analysis found a higher rate of severe and life-threatening infections in patients with RET-mutant lung cancer ...

With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.

You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

The FDA granted an accelerated approval to asciminib for newly diagnosed Ph+ chronic myeloid leukemia in the chronic phase.

Surveyed individuals who identified as a racial or ethnic minority reported difficulties discussing cancer diagnosis and treatment. Typical stories shared about “going flat” after a mastectomy may not ...

FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...